Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Modèle: DM 540737-29-9
Appearance: White to off-white powder
Single Impurity: ≤0.1%
Total Impurities: ≤0.5%
Loss On Drying: ≤0.5%
Residue On Ignition: ≤0.1%
Assay: 98.0%~102.0%
Détails d'emballage: 25 kg / tambour
productivité: Stock avbailable
transport: Ocean,Land,Air,Express,Others
Lieu d'origine: Hebei, Chine
Soutenir: STOCK AVAILABLE
Certificats : ISO9001
Hafen: SHANGHAI,SHENZHEN,BEIJING
Type de paiement: L/C,T/T,Paypal,Others
Incoterm: FOB,CFR,CIF,CPT,CIP,FCA
Tofacitinib Citrate CAS n ° 540737-29-9
Nom de Produ CT: Citrate de tofacitinib
Synonymes: 3 - ((3R, 4R) -4-méthyl-3- (méthyl (7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino) pipéridine-1-yl) -3-oxopropanenitrile citrate ;
Cit-690550 Citrate ; Tofacitinib (CP-690550) Citrate ; Tofacitinib citratet ;
3- {4-méthyl-3- [méthyl- (7h-pyrrolo [2,3-d] pyrimidine-4-yl) -amino] -pipéridine-1-yl} -3-oxo-propionitrile
CA S No.: 540737-29-9
Apparence: poudre cristalline blanche
Impureté unique : ≤0,1%
Impuretés totales : ≤0,5%
Perte de séchage : ≤0,5%
Résidu sur l'allumage : ≤0,1%
Dosage: 98,0% ~ 102,0%
Groupes de Produits : API et intermédiaires > Poudre API
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now